Evolutionary measures show that recurrence of DCIS is distinct from progression to breast cancer.

The event-free survival curves of patients stratified using their relative risk were highly significant, with median times to event that differed between groups in 123 months for non-invasive recurrence (Fig. 7 B) and > 69 months for progression (Fig. 7 D).

also in 132,142 other papers